20/20 Biolabs, Inc. (AIDX) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by 20/20 Biolabs, Inc. on August 18, 2026. The meeting was conducted via live webcast. As of the record date (June 22, 2026), there were 12,251,198 shares of common stock outstanding. A total of 4,256,837 shares were represented at the meeting, constituting a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders voted on five proposals. The results were as follows:
- Proposal 1 (Election of Directors): All six nominees were elected. Significant broker non-votes (1,433,721) were recorded for each director.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of dbbmckennon as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Proposal 3 (Charter Amendment): Failed. The Company did not receive sufficient votes to approve this proposal.
- Proposal 4 (2026 Equity Incentive Plan): Approved by stockholders.
- Proposal 5 (Adjournment): Approved by stockholders to allow for the solicitation of additional proxies if necessary.
Outlook, Risks, and Unusual Items
Due to the failure of Proposal 3 (Charter Amendment), the Annual Meeting was adjourned specifically regarding this proposal until September 16, 2026, at 10:00 a.m. Eastern Time. Stockholders may attend the adjourned meeting via the same webinar portal used for the original meeting. The filing does not contain specific management commentary on financial outlook or new risk factors beyond the procedural adjournment.
Key Facts for Investor Verification
- Verify the specific terms of the failed Charter Amendment (Proposal 3) and the rationale for the adjournment.
- Confirm the details of the 2026 Equity Incentive Plan approved in Proposal 4, including share limits and vesting schedules.
- Monitor the outcome of the adjourned meeting on September 16, 2026, regarding the Charter Amendment.
- Note the high volume of broker non-votes (1,433,721) in the director election, indicating shares held in street name where brokers lacked discretionary voting power.